BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 7124857)

  • 1. Prognostic features of endometrial cancer in estrogen users and obese women.
    La Vecchia C; Franceschi S; Gallus G; Decarli A; Colombo E; Liberati A; Tognoni G
    Am J Obstet Gynecol; 1982 Oct; 144(4):387-90. PubMed ID: 7124857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exogenous estrogen and endometrial carcinoma: case-control and incidence study.
    McDonald TW; Annegers JF; O'Fallon WM; Dockerty MB; Malkasian GD; Kurland LT
    Am J Obstet Gynecol; 1977 Mar; 127(6):572-80. PubMed ID: 190887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oestrogen use and survival in endometrial cancer.
    Collins J; Donner A; Allen LH; Adams O
    Lancet; 1980 Nov; 2(8201):961-4. PubMed ID: 6107599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of endometrial cancer.
    Voigt LF; Weiss NS
    Cancer Treat Res; 1989; 49():1-21. PubMed ID: 2577197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Estrogen therapy and carcinoma of the endometrium (author's transl)].
    Völker W; Kannengiesser U; Majewski A; Vasterling HW
    Geburtshilfe Frauenheilkd; 1978 Sep; 38(9):735-43. PubMed ID: 210085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen--a cause of gynecologic cancer?
    Lucas WE
    Cancer; 1981 Jul; 48(2 Suppl):451-4. PubMed ID: 7023661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The epidemiology of endometrial cancer in young women.
    Henderson BE; Casagrande JT; Pike MC; Mack T; Rosario I; Duke A
    Br J Cancer; 1983 Jun; 47(6):749-56. PubMed ID: 6860544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of estrogens and progesterone in the etiology and prevention of endometrial cancer: review.
    Gambrell RD; Bagnell CA; Greenblatt RB
    Am J Obstet Gynecol; 1983 Jul; 146(6):696-707. PubMed ID: 6307050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endometrial cancer and estrogen use. Report of a large case-control study.
    Antunes CM; Strolley PD; Rosenshein NB; Davies JL; Tonascia JA; Brown C; Burnett L; Rutledge A; Pokempner M; Garcia R
    N Engl J Med; 1979 Jan; 300(1):9-13. PubMed ID: 213722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen regimen of women with endometrial carcinoma. A retrospective case-control study at Radiumhemmet.
    Obrink A; Bunne G; Collén J; Tjernberg B
    Acta Obstet Gynecol Scand; 1981; 60(2):191-7. PubMed ID: 7246086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oestrogens and obesity as risk factors for endometrial cancer in Italy.
    La Vecchia C; Franceschi S; Gallus G; Decarli A; Colombo E; Mangioni C; Tognoni G
    Int J Epidemiol; 1982 Jun; 11(2):120-6. PubMed ID: 7095961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exogenous estrogens and endometrial cancer: a case-control study and assessment of potential biases.
    Spengler RF; Clarke EA; Woolever CA; Newman AM; Osborn RW
    Am J Epidemiol; 1981 Oct; 114(4):497-506. PubMed ID: 7304580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical significance of analysis of estrogen and progesterone receptors in human uterine tissues].
    Maleeva A; Milkov V
    Akush Ginekol (Mosk); 1991 May; (5):55-7. PubMed ID: 1897675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for adenomatous endometrial hyperplasia: a case-control study.
    Kreiger N; Marrett LD; Clarke EA; Hilditch S; Woolever CA
    Am J Epidemiol; 1986 Feb; 123(2):291-301. PubMed ID: 3946378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endometrial carcinoma: clinical-pathologic comparison of cases in postmenopausal women receiving and not receiving exogenous estrogens.
    Silverberg SG; Mullen D; Faraci JA; Makowski EL; Miller A; Finch JL; Sutherland JV
    Cancer; 1980 Jun; 45(12):3018-26. PubMed ID: 7388746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of cancer of the endometrium.
    Mahboubi E; Eyler N; Wynder EL
    Clin Obstet Gynecol; 1982 Mar; 25(1):5-17. PubMed ID: 7039906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endometrial carcinoma: histopathology, survival, and exogenous estrogens.
    Smith DC; Prentice RL; Bauermeister DE
    Gynecol Obstet Invest; 1981; 12(4):169-79. PubMed ID: 7250780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endometrial cancer in postmenopausal women with and without previous estrogen replacement treatment: comparison of clinical and histopathological characteristics.
    Nyholm HC; Nielsen AL; Norup P
    Gynecol Oncol; 1993 May; 49(2):229-35. PubMed ID: 8504992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for endometrial cancer at different ages.
    La Vecchia C; Franceschi S; Decarli A; Gallus G; Tognoni G
    J Natl Cancer Inst; 1984 Sep; 73(3):667-71. PubMed ID: 6590913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of long-term estrogen replacement therapy. II. Neoplasia.
    Hammond CB; Jelovsek FR; Lee KL; Creasman WT; Parker RT
    Am J Obstet Gynecol; 1979 Mar; 133(5):537-47. PubMed ID: 220875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.